BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 30, 2026
See today's BioWorld
Home
» Inozyme raises $67M in series A2 financing
To read the full story,
subscribe
or
sign in
.
Inozyme raises $67M in series A2 financing
April 11, 2019
By
Lee Landenberger
Cambridge, Mass.-based Inozyme Pharma Inc. just added $67 million to its financing with a series A2 boost led by Pivotal Bioventure Partners and Sofinnova Investments.
BioWorld
